{"url_path":"/sec/rpid/8-k/2026-05-13/item-2-02","section_key":"item-2-02","section_title":"Item 2.02 Results of Operations and Financial Condition.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1380106/0001380106-26-000067-index.html","accession_number":"0001380106-26-000067","cik":"0001380106","ticker":"RPID","issuer_name":"RAPID MICRO BIOSYSTEMS, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1380106/0001380106-26-000067-index.html","primary_entity_key":"0001380106","primary_entity_name":"RAPID MICRO BIOSYSTEMS, INC."},"word_count":138,"has_tables":true,"body_markdown":"Item 2.02\n\nResults of Operations and Financial Condition.\n\nOn May 13, 2026, Rapid Micro Biosystems, Inc. (the “Company”) issued a press release announcing its financial results for its its first quarter ended March 31, 2026. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference in its entirety.\n\nThe information furnished under Item 2.02, including Exhibit 99.1 attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended (the \"Securities Act\"), or the Exchange Act, except as otherwise expressly stated in such filing."}